Epstein-Barr Virus Infections D020031

Diseases [C] » Infections [C01] » Virus Diseases » DNA Virus Infections » Herpesviridae Infections » Epstein-Barr Virus Infections

Diseases [C] » Infections [C01] » Virus Diseases » Tumor Virus Infections » Epstein-Barr Virus Infections

Description

Infection with human herpesvirus 4 (HERPESVIRUS 4, HUMAN); which may facilitate the development of various lymphoproliferative disorders. These include BURKITT LYMPHOMA (African type), INFECTIOUS MONONUCLEOSIS, and oral hairy leukoplakia (LEUKOPLAKIA, HAIRY).   MeSH

Hierarchy View

Subtype Terms (3)

Burkitt Lymphoma
160 drugs (93 approved, 67 experimental)

Infectious Mononucleosis
7 drugs (4 approved, 3 experimental)

Leukoplakia, Hairy
1 approved drug


Approved Indicated Drugs (1)

Phase 3 Indicated Drugs (1)


Organization Involved with Phase 3 Indications (3)

Organization Involved with Phase 1 Indications (1)

Organization Involved with Other Experimental Indications (2)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.